ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Deerfield Management is backing research at yet another institution. The health care venture firm says it will invest up to $80 million in a center at Dana-Farber Cancer Institute that will study protein degradation, the process whereby unwanted proteins are directed to the proteasome to be broken down. The center will solicit ideas from Dana-Farber and Harvard Medical School researchers for small-molecule protein degraders. Deerfield also has pacts with Broad Institute of MIT & Harvard, Johns Hopkins University, and the University of North Carolina, Chapel Hill.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter